Jeff Calcagno

Jeff Calcagno

Corporate Officer/Principal bei VIR BIOTECHNOLOGY, INC.

Finance
Health Technology
Consumer Services

Profil

Dr. Jeff Calcagno, MD, is a Principal at Johnson & Johnson Development Corp.
Dr. Calcagno began his business career as a management consultant at McKinsey & Company.
He later served as a healthcare research analyst at JP Morgan Hambrecht & Quist.
As an entrepreneur, he ran corporate development and operations for WIDCOMM, a technology company acquired by Broadcom, and served as CFO & CBO for Vela Pharmaceuticals, a venture-backed drug development company.
From 2006 to 2010 he was a Principal & Kauffman Fellow at Scale Venture Partners, a venture fund with over $1B under management.
He has over two decades of healthcare and business experience: as a clinician, management consultant, research analyst, entrepreneur, and venture investor.
Dr. Calcagno graduated Phi Beta Kappa in Biology from Harvard College and earned an MD from Harvard Medical School, where he was a Rotary International Ambassadorial Scholar.

Aktive Positionen von Jeff Calcagno

UnternehmenPositionBeginn
VIR BIOTECHNOLOGY, INC. Corporate Officer/Principal 15.05.2023
Alle aktiven Positionen von Jeff Calcagno

Ehemalige bekannte Positionen von Jeff Calcagno

UnternehmenPositionEnde
Johnson & Johnson Innovation Corporate Officer/Principal 01.04.2023
Private Equity Investor 31.05.2011
Corporate Officer/Principal 31.12.1990
Private Equity Investor -
WIDCOMM, Inc. Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Jeff Calcagno im Detail an

Ausbildung von Jeff Calcagno

Harvard University Undergraduate Degree
Harvard Medical School Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jeff Calcagno im Detail an

Beziehungen

98

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
VIR BIOTECHNOLOGY, INC.

Health Technology

Private Unternehmen7

Health Technology

Finance

Finance

Finance

Commercial Services

WIDCOMM, Inc.

Communications

Johnson & Johnson Innovation

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Jeff Calcagno